Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601). Sato S, Kunisaki C, Tamura Y, Yago A, et al. Anticancer Res 2023;43:5663-5670.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sato S, Kunisaki C, Tamura Y, Yago A, et al. Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601). Anticancer Res 2023;43:5663-5670.
PMID: 38030195